|
1
|
Elzinga-Tinke JE, Dohle GR and Looijenga
LH: Etiology and early pathogenesis of malignant testicular germ
cell tumors: Towards possibilities for preinvasive diagnosis. Asian
J Androl. 17:381–393. 2015.PubMed/NCBI
|
|
2
|
Brydøy M1, Fosså SD, Klepp O, Bremnes RM,
Wist EA and Wentzel-Larsen T: Paternity and testicular function
among testicular cancer survivors treated with two to four cycles
of cisplatin-based chemotherapy. Eur Urol. 58:134–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Efstathiou E and Logothetis CJ: Review of
late complications of treatment and late relapse in testicular
cancer. J Natl Compr Canc Netw. 4:1059–1070. 2006.PubMed/NCBI
|
|
4
|
He B, Tong X, Wang L, Wang Q, Ye H, Liu B,
Hong X, Tao L and Harris AL: Tramadol and flurbiprofen depress the
cytotoxicity of cisplatin via their effects on gap junctions. Clin
Cancer Res. 15:5803–5810. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shishido SN and Nguyen TA: Gap junction
enhancer increases efficacy of cisplatin to attenuate mammary tumor
growth. PLoS One. 7:e449632012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saez JC, Berthoud VM, Branes MC, Martinez
AD and Beyer EC: Plasma membrane channels formed by connexins:
Their regulation and functions. Physiol Rev. 83:1359–1400. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Weider K, Bergmann M and Brehm R: Connexin
43: Its regulatory role in testicular junction dynamics and
spermatogenesis. Histol Histopathol. 26:1343–1352. 2011.PubMed/NCBI
|
|
8
|
Jensen R and Glazer PM:
Cell-interdependent cisplatin killing by Ku/DNA-dependent protein
kinase signaling transduced through gap junctions. Proc Natl Acad
Sci USA. 101:6134–6139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Contreras JE, Sánchez HA, Véliz LP,
Bukauskas FF, Bennett MV and Sáez JC: Role of connexin-based gap
junction channels and hemichannels in ischemia-induced cell death
in nervous tissue. Brain Res Brain Res Rev. 47:290–303. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kar R, Riquelme MA, Werner S and Jiang JX:
Connexin 43 channels protect osteocytes against oxidative
stress-induced cell death. J Bone Miner Res. 28:1611–1621. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakase T, Fushiki S and Naus CC:
Astrocytic gap junctions composed of connexin 43 reduce apoptotic
neuronal damage in cerebral ischemia. Stroke. 34:1987–1993. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hong X, Wang Q, Yang Y, Zheng S, Tong X,
Zhang S, Tao L and Harris A: Gap junctions propagate opposite
effects in normal and tumor testicular cells in response to
cisplatin. Cancer Lett. 317:165–171. 2012. View Article : Google Scholar
|
|
13
|
Subramanian S, Emami H, Vucic E, Singh P,
Vijayakumar J, Fifer KM, Alon A, Shankar SS, Farkouh M, Rudd JH, et
al: High-dose atorvastatin reduces periodontal inflammation: A
novel pleiotropic effect of statins. J Am Coll Cardiol.
62:2382–2391. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hwang KE, Kwon SJ, Kim YS, Park DS, Kim
BR, Yoon KH, Jeong ET and Kim HR: Effect of simvastatin on the
resistance to EGFR tyrosine kinase inhibitors in a non-small cell
lung cancer with the T790M mutation of EGFR. Exp Cell Res.
323:288–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang L, Fu Y, Peng J, Wu D, Yu M, Xu C,
Wang Q and Tao L: Simvastatin-induced up-regulation of gap
junctions composed of connexin 43 sensitize Leydig tumor cells to
etoposide: An involvement of PKC pathway. Toxicology. 312:149–157.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koreen IV, Elsayed WA, Liu YJ and Harris
AL: Tetracycline-regulated expression enables purification and
functional analysis of recombinant connexin channels from mammalian
cells. Biochem J. 383:111–119. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Laird DW: Connexin phosphorylation as a
regulatory event linked to gap junction internalization and
degradation. Biochim Biophys Acta. 1711:172–182. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boekelheide K: Mechanisms of toxic damage
to spermatogenesis. J Natl Cancer Inst Monogr. 34:6–8. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Harman JG and Richburg JH:
Cisplatin-induced alterations in the functional spermatogonial stem
cell pool and niche in C57/BL/6J mice following a clinically
relevant multi-cycle exposure. Toxicol Lett. 227:99–112. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pogach LM, Lee Y, Gould S, Giglio W,
Meyenhofer M and Huang HF: Characterization of cis-platinum-induced
Sertoli cell dysfunction in rodents. Toxicol Appl Pharmacol.
98:350–361. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nambu A, Kumamoto Y and Mikuma N: Effects
of anti-cancer agents on cultured rat Sertoli cells. Nihon
Hinyokika Gakkai Zasshi. 86:1132–1136. 1995.In Japanese. PubMed/NCBI
|
|
22
|
Erdlenbruch B, Nier M, Kern W, Hiddemann
W, Pekrun A and Lakomek M: Pharmacokinetics of cisplatin and
relation to nephrotoxicity in paediatric patients. Eur J Clin
Pharmacol. 57:393–402. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carette D, Weider K, Gilleron J, Giese S,
Dompierre J, Bergmann M, Brehm R, Denizot JP, Segretain D and
Pointis G: Major involvement of connexin 43 in seminiferous
epithelial junction dynamics and male fertility. Dev Biol.
346:54–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sridharan S, Simon L, Meling DD, Cyr DG,
Gutstein DE, Fishman GI, Guillou F and Cooke PS: Proliferation of
adult Sertoli cells following conditional knockout of the Gap
junctional protein GJA1 (connexin 43) in mice. Biol Reprod.
76:804–812. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Günther S, Fietz D, Weider K, Bergmann M
and Brehm R: Effects of a murine germ cell-specific knockout of
connexin 43 on connexin expression in testis and fertility.
Transgenic Res. 22:631–641. 2013. View Article : Google Scholar
|
|
26
|
Qiu L, Zhang X, Zhang X, Zhang Y, Gu J,
Chen M, Zhang Z, Wang X and Wang SL: Sertoli cell is a potential
target for perfluorooctane sulfonate-induced reproductive
dysfunction in male mice. Toxicol Sci. 135:229–240. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van der Meij E, Koning GG, Vriens PW,
Peeters MF, Meijer CA, Kortekaas KE, Dalman RL, van Bockel JH,
Hanemaaijer R, Kooistra T, et al: A clinical evaluation of statin
pleiotropy: Statins selectively and dose-dependently reduce
vascular inflammation. PLoS One. 8:e538822013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Uzzan B, Cohen R, Nicolas P, Cucherat M
and Perret GY: Effects of statins on bone mineral density: A
meta-analysis of clinical studies. Bone. 40:1581–1587. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Greener ID, Sasano T, Wan X, Igarashi T,
Strom M, Rosenbaum DS and Donahue JK: Connexin43 gene transfer
reduces ventricular tachycardia susceptibility after myocardial
infarction. J Am Coll Cardiol. 60:1103–1110. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Naji F, Suran D, Kanic V, Vokac D and
Sabovic M: Comparison of atorvastatin and simvastatin in prevention
of atrial fibrillation after successful cardioversion. Int Heart J.
50:153–160. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Aravindakshan J and Cyr DG: Nonylphenol
alters connexin 43 levels and connexin 43 phosphorylation via an
inhibition of the p38-mitogen-activated protein kinase pathway.
Biol Reprod. 72:1232–2140. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee YM, Chen WF, Chou DS, Jayakumar T, Hou
SY, Lee JJ, Hsiao G and Sheu JR: Cyclic nucleotides and
mitogen-activated protein kinases: Regulation of simvastatin in
platelet activation. J Biomed Sci. 17:452010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li JC, Mruk D and Cheng CY: The
inter-Sertoli tight junction permeability barrier is regulated by
the interplay of protein phosphatases and kinases: An in vitro
study. J Androl. 22:847–856. 2001.PubMed/NCBI
|
|
34
|
Le HT, Sin WC, Lozinsky S, Bechberger J,
Vega JL, Guo XQ, Sáez JC and Naus CC: Gap junction intercellular
communication mediated by connexin43 in astrocytes is essential for
their resistance to oxidative stress. J Biol Chem. 289:1345. 2014.
View Article : Google Scholar :
|
|
35
|
Pocrnich CE, Shao Q, Liu H, Feng MM,
Harasym S, Savage M, Khimdas S, Laird DW and Hutnik CM: The effect
of connexin43 on the level of vascular endothelial growth factor in
human retinal pigment epithelial cells. Graefes Arch Clin Exp
Ophthalmol. 250:515–522. 2012. View Article : Google Scholar
|
|
36
|
Rottlaender D, Boengler K, Wolny M,
Michels G, Endres-Becker J, Motloch LJ, Schwaiger A, Buechert A,
Schulz R, Heusch G, et al: Connexin 43 acts as a cytoprotective
mediator of signal transduction by stimulating mitochondrial
KATP channels in mouse cardiomyocytes. J Clin Invest.
120:1441–1453. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nakamura TY, Yamamoto I, Kanno Y, Shiba Y
and Goshima K: Metabolic coupling of glutathione between mouse and
quail cardiac myocytes and its protective role against oxidative
stress. Circ Res. 74:806–816. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Igarashi I, Maejima T, Kai K, Arakawa S,
Teranishi M and Sanbuissho A: Role of connexin 32 in acetaminophen
toxicity in a knockout mice model. Exp Toxicol Pathol. 66:103–110.
2014. View Article : Google Scholar
|
